New HIV Prevention Technologies Effer Greater Choice

Interview by Laura Ramos Tomás

Professor Mitzy Gafos, Professor of Social Science and Global Health at the London School of Hygiene and Tropical Medicine (LSHTM), speaks with FPNN Community Reporter Laura Ramos Tomás, expressing optimism about recent data on long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and its potential to expand prevention choices across various settings.

Additionally, the WHO has released new guidelines recommending CAB-LA as a safe and highly effective prevention option for people at substantial risk of HIV infection, urging countries to consider its use.

---